318 related articles for article (PubMed ID: 19346369)
1. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Alifrangis M; Lusingu JP; Mmbando B; Dalgaard MB; Vestergaard LS; Ishengoma D; Khalil IF; Theander TG; Lemnge MM; Bygbjerg IC
Am J Trop Med Hyg; 2009 Apr; 80(4):523-7. PubMed ID: 19346369
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
3. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
4. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
[TBL] [Abstract][Full Text] [Related]
5. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
[TBL] [Abstract][Full Text] [Related]
6. Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo.
Baraka V; Delgado-Ratto C; Nag S; Ishengoma DS; Madebe RA; Mavoko HM; Nabasumba C; Lutumba P; Alifrangis M; Van Geertruyden JP
Int J Antimicrob Agents; 2017 Apr; 49(4):456-464. PubMed ID: 28237831
[TBL] [Abstract][Full Text] [Related]
7. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
[TBL] [Abstract][Full Text] [Related]
8. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Bwire GM; Mikomangwa WP; Kilonzi M
BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
Svigel SS; Adeothy A; Kpemasse A; Houngbo E; Sianou A; Saliou R; Patton ME; Dagnon F; Halsey ES; Tchevoede A; Udhayakumar V; Lucchi NW
Malar J; 2021 Feb; 20(1):72. PubMed ID: 33546703
[TBL] [Abstract][Full Text] [Related]
11. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.
Alifrangis M; Enosse S; Pearce R; Drakeley C; Roper C; Khalil IF; Nkya WM; Rønn AM; Theander TG; Bygbjerg IC
Am J Trop Med Hyg; 2005 Feb; 72(2):155-62. PubMed ID: 15741552
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
14. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
Peek R; VAN Gool T; Panchoe D; Greve S; Bus E; Resida L
Am J Trop Med Hyg; 2005 Nov; 73(5):833-8. PubMed ID: 16282289
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.
Alifrangis M; Dalgaard MB; Lusingu JP; Vestergaard LS; Staalsoe T; Jensen AT; Enevold A; Rønn AM; Khalil IF; Warhurst DC; Lemnge MM; Theander TG; Bygbjerg IC
J Infect Dis; 2006 Jun; 193(12):1738-41. PubMed ID: 16703518
[TBL] [Abstract][Full Text] [Related]
18. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
19. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
